A Rare Case of Multiple Gastrointestinal Stromal Tumors Coexisting with a Rectal Adenocarcinoma in a Patient with Attenuated Familial Adenomatous Polyposis Syndrome and a Mini Review of the Literature.
AFAP
adenocarcinoma
case report
multiple GIST
rectal
surgery
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
18 Aug 2022
18 Aug 2022
Historique:
received:
18
07
2022
revised:
13
08
2022
accepted:
15
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
Multiple gastrointestinal stromal tumors (GISTs) are extremely rare entities that exist either as spontaneous GISTs or as part of various syndromes, such as Carney's triad and type I neurofibromatosis (NF1). Attenuated familial adenomatous polyposis (AFAP) is a variant of familial adenomatous polyposis (FAP) with a milder clinical presentation. Both GISTs and AFAP have been reported to coexist with colorectal cancer, but the coexistence of GISTs and AFAP has never been reported in the literature before. A 45-year-old male patient with known AFAP arrived scheduled for a total colectomy and ileo-rectal anastomosis due to the malignancy of one of the previously biopsied polyps of the upper rectum. Intraoperatively, multiple nodular tumors were found at the jejunum within a length of 45 cm, for which an enterectomy and enteroanastomosis were performed. A histopathological examination of the whole colectomy specimen confirmed the presence of multiple polyps in the large intestine along with a rectal invasive adenocarcinoma. At the same time, in the examined part of the small intestine, 15 GISTs sized from 0.5 to 2.0 cm of prognostic group I, were identified. The patient's postoperative course was uncomplicated. Multiple GISTs may present as an asymptomatic disease, and the same thing is true for colorectal cancer. Therefore, the appropriate screening is crucial for entities such as AFAP, since the surgery was performed because of the malignant transformation in one of the polyps and revealed multiple GISTs, as well.
Sections du résumé
BACKGROUND
BACKGROUND
Multiple gastrointestinal stromal tumors (GISTs) are extremely rare entities that exist either as spontaneous GISTs or as part of various syndromes, such as Carney's triad and type I neurofibromatosis (NF1). Attenuated familial adenomatous polyposis (AFAP) is a variant of familial adenomatous polyposis (FAP) with a milder clinical presentation. Both GISTs and AFAP have been reported to coexist with colorectal cancer, but the coexistence of GISTs and AFAP has never been reported in the literature before.
CASE REPORT
METHODS
A 45-year-old male patient with known AFAP arrived scheduled for a total colectomy and ileo-rectal anastomosis due to the malignancy of one of the previously biopsied polyps of the upper rectum. Intraoperatively, multiple nodular tumors were found at the jejunum within a length of 45 cm, for which an enterectomy and enteroanastomosis were performed. A histopathological examination of the whole colectomy specimen confirmed the presence of multiple polyps in the large intestine along with a rectal invasive adenocarcinoma. At the same time, in the examined part of the small intestine, 15 GISTs sized from 0.5 to 2.0 cm of prognostic group I, were identified. The patient's postoperative course was uncomplicated.
CONCLUSION
CONCLUSIONS
Multiple GISTs may present as an asymptomatic disease, and the same thing is true for colorectal cancer. Therefore, the appropriate screening is crucial for entities such as AFAP, since the surgery was performed because of the malignant transformation in one of the polyps and revealed multiple GISTs, as well.
Identifiants
pubmed: 36013583
pii: medicina58081116
doi: 10.3390/medicina58081116
pmc: PMC9415979
pii:
doi:
Types de publication
Case Reports
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Lancet Oncol. 2012 Jun;13(6):579-88
pubmed: 22503032
Gastric Cancer. 2016 Jan;19(1):3-14
pubmed: 26276366
BMC Cancer. 2019 Dec 5;19(1):1196
pubmed: 31805970
Fam Cancer. 2003;2(1):43-55
pubmed: 14574166
Curr Treat Options Oncol. 2006 Nov;7(6):427-37
pubmed: 17032555
Ann Surg Oncol. 2020 Aug;27(8):2812-2821
pubmed: 32040699
Clin Cancer Res. 2012 Aug 15;18(16):4458-64
pubmed: 22718859
Lancet. 2009 Mar 28;373(9669):1097-104
pubmed: 19303137
Hum Genet. 1995 Dec;96(6):705-10
pubmed: 8522331
Orphanet J Rare Dis. 2009 Oct 12;4:22
pubmed: 19822006
J Clin Oncol. 2008 Nov 20;26(33):5352-9
pubmed: 18955458
Eur J Cancer. 2016 Jan;52:173-80
pubmed: 26687836
JAMA. 2012 Mar 28;307(12):1265-72
pubmed: 22453568
Prz Gastroenterol. 2022;17(2):89-95
pubmed: 35664027
Am J Hum Genet. 1998 Jun;62(6):1290-301
pubmed: 9585611
Cancer Manag Res. 2019 Jul 25;11:7031-7038
pubmed: 31413638
Semin Diagn Pathol. 2006 May;23(2):70-83
pubmed: 17193820
Mayo Clin Proc. 1999 Jun;74(6):543-52
pubmed: 10377927
J Clin Oncol. 2014 May 20;32(15):1563-70
pubmed: 24638003
N Engl J Med. 2004 Jun 3;350(23):2343-51
pubmed: 15175436
J Clin Oncol. 2007 Jan 1;25(1):102-9
pubmed: 17194911
Hum Pathol. 2002 May;33(5):459-65
pubmed: 12094370
Ann Med Surg (Lond). 2021 Jan 22;62:365-368
pubmed: 33552495
Surg Oncol. 2019 Jun;29:64-70
pubmed: 31196495
Int J Clin Exp Pathol. 2012;5(9):852-62
pubmed: 23119102
Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
pubmed: 17090188
Lancet Oncol. 2012 Mar;13(3):265-74
pubmed: 22153892
Clin Cancer Res. 2014 Dec 1;20(23):6105-16
pubmed: 25294914
Endocr Relat Cancer. 2014 Aug;21(4):567-77
pubmed: 24859990